RX-360 INTERNATIONAL PHARMACEUTICA… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

JAMES FRIES

Phone

8882181164

Tax Period

2024-01-01 to 2024-12-31

RX-360 INTERNATIONAL PHARMACEUTICAL SUPPLY CHAIN CONSORTIUM, founded in 2009, is a community nonprofit in the Employment sector that reported $5.0M in total revenue in fiscal year 2024. Revenue grew 18% year-over-year, indicating healthy expansion. The organization ran a surplus of $781K, a strong 16% operating margin.

Mission

THE ORGANIZATION'S MISSION IS TO PROTECT PATIENT SAFETY BY SHARING INFORMATION AND DEVELOPING PROCESSES RELATED TO THE INTEGRITY OF THE HEALTHCARE SUPPLY CHAIN AND THE QUALITY OF MATERIALS WITHIN THE SUPPLY CHAIN.

Program Service Accomplishments

Program 1

Expenses: $2,648,082 Revenue: $4,896,067

ENHANCING THE SECURITY OF THE PHARMACEUTICAL SUPPLY CHAIN THROUGH TWO AUDIT PROGRAMS AND RESEARCH PROGRAMS. THE RX-360 AUDIT SHARING PROGRAM ALLOWS RX-360 TO LICENSE SUPPLIER QUALITY AUDITS CONDUCTED BY RX-360 IN A CONFIDENTIAL MANNER. THE RX-360 JOINT AUDITING PROGRAM ALLOWS RX-360 TO CONDUCT JOINT CONDUCT JOINT QUALITY AUDITS OF PHARMACEUTICAL SUPPLIES. RX-360 ALSO ANALYZES NEW LEGISLATION, REGULATIONS, STANDARDS, AND OTHER DEVELOPMENTS THAT IMPACT THE PHARMACEUTICAL SUPPLY CHAIN, AND MAKES THIS INFORMATION AVAILABLE TO RX-360 MEMBERS AND THE PUBLIC VIA RX-360'S WEBSITE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $4,896,067

Investment Income $73,741

Other Revenue $1,849

TOTAL REVENUE $4,971,657

Expense Breakdown

Grants Paid $0

Salaries & Benefits $2,129,676

Fundraising Expenses $0

Program Expenses $2,648,082

Other Expenses $2,060,775

TOTAL EXPENSES $4,190,451

Year-over-Year Comparison

	2024	2023	Change
Revenue	$4,971,657	$4,214,492	+0.2%
Expenses	$4,190,451	$3,541,635	+0.2%
Net Income	$781,206	$672,857	+0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$321,710

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KATHLEEN SILVA	TREASURER	3.00	Officer Director	$0	$0	$0
ROB WELSH	CHAIR EMERITUS	3.00	Officer Director	$0	$0	$0
SCOTT KAMMER	CHAIR	3.00	Officer Director	$0	$0	$0
JENNIFER STONE	VICE CHAIR	3.00	Officer Director	$0	$0	$0
CHRISTIAN LIEBL	SECRETARY	2.00	Officer Director	$0	$0	$0
TOM LUPO	DIRECTOR	2.00	Director	$0	$0	$0
REBECCA ALCANTARA	DIRECTOR	2.00	Director	$0	$0	$0
ANTHONY DAMAS UNTIL 624	DIRECTOR	2.00	Director	$0	$0	$0
CHRIS TRENT START 724	DIRECTOR	2.00	Director	$0	$0	$0
CHRISTY MOCNY	DIRECTOR	2.00	Director	$0	$0	$0
JENNIFER GOODMAN UNTIL 624	DIRECTOR	2.00	Director	$0	$0	$0
ROB SMITH	DIRECTOR	2.00	Director	$0	$0	$0
BILL CAMPAGNA	DIRECTOR	2.00	Director	$0	$0	$0
ELISE TREUVEY UNTIL 624	DIRECTOR	2.00	Director	$0	$0	$0
VARSHA ODIYANDA START 724	DIRECTOR	2.00	Director	$0	$0	$0
AMBER HOLLNER	DIRECTOR	2.00	Director	$0	$0	$0
JOHANNES GROSS	DIRECTOR	2.00	Director	$0	$0	$0
LIAM KEARY	DIRECTOR	2.00	Director	$0	$0	$0
TONY ZOOK	DIRECTOR	2.00	Director	$0	$0	$0
JAMES FRIES	CEO	40.00	Officer	$319,223	$2,487	$321,710
BENJAMIN MILLS	SENIOR DIRECTOR OF OPERATIONS	40.00	Highest	$151,689	$27,830	$179,519
KENDALL FESHUK	MANAGER, MEMBER MANAGEMENT	40.00	Highest	$136,440	$15,232	$151,672
GORDON CURTIS	SENIOR DIRECTOR OF FINANCE	40.00	Highest	$109,309	$5,921	$115,230

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$4,971,657	$4,190,451	$5,825,545	$781,206
2023	$4,214,492	$3,541,635	$3,660,812	$672,857
2022	$3,588,442	$2,988,163	$3,000,257	$600,279
2021	$2,943,923	$2,053,844	$2,136,683	$890,079
2020	$1,803,758	$1,555,010	$961,291	$248,748
2019	$1,467,673	$1,489,161	$708,888	$-21,488
2018	$1,927,037	$1,843,250	$815,374	$83,787

RX-360 INTERNATIONAL PHARMACEUTICAL SUPPLY CHAIN CONSORTIUM